Point72 Asset Management, L.P. 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:53 pm Sale |
2024-09-30 | 13G | C4 Therapeutics, Inc. CCCC |
Point72 Asset Management, L.P. | 1,313,747 1.900% |
-1,362,949 (-50.92%) |
Filing |
| 2024-01-04 4:15 pm Purchase |
2024-01-03 | 13G | C4 Therapeutics, Inc. CCCC |
Point72 Asset Management, L.P. | 2,676,696 5.400% |
2,676,696 (New Position) |
Filing |